Sleep apnea in patients receiving growth hormone

Clinical Pediatrics

Volumn 36, Issue 6, 1997, Pages 321-326

  Gerard, James M ^a,b   Garibaldi, Luigi ^a   Myers, Susan E ^a   Aceto Jr , Thomas ^a   Kotagal, Suresh ^a   Gibbons, Vincent P ^a   Stith, John ^a   Weber, Colleen ^a  

^a S Louis Univ Hlth Sciences Center   (United States)

^b Cardinal Glennon Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATREM;

ADENOTONSILLECTOMY; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; CORTICOTROPIN DEFICIENCY; DISEASE ASSOCIATION; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERTROPHY; KIDNEY FAILURE; MALE; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROME; SNORING; TONSIL DISEASE; TURNER SYNDROME;

EID: 0030985861     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289703600602     Document Type: Article

References (16)

1. Hart TB, Radow SK, Blackard WG, et al. Sleep apnea in active acromegaly. Arch Intern Med. 1985;145:865-866.
2. Mickelson SA, Rosenthal LD, Rock JP, et al. Obstructive sleep apnea syndrome and acromegaly. Otolyarngol Head Neck Surg. 1994;111:25-30.
3. Pekkarinen T, Partinen M, Pelkonen R, et al. Sleep apnea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clin Endocrinol. 1987;27:649-654.
4. De Boer H, Roelfsema M, Frolich H, et al. Plasma growth hormone profiles and sleep: a study of 13 treated acromegalics. Clin Endocrinol. 1989; 30:251-261.
5. Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med. 1991;115:527-532.
6. Kelley KW. Growth hormone, lymphocytes and macrophages. Biochem Pharmacol. 1989;38:705-713.
7. Murphy WJ, Durum SK, Anver MR, et al. Immunologie and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J Immunol. 1992;148:3799-805.
8. Palmer JM, Wallis M. Human growth hormone stimulates somatomcdin C/insulin-like growth factor-1 production by the human lymphoid cell line, im-9. Mol Cell Endocrinol. 1989;63:167-173.
9. Berczi I, Nagy E, DeToledo SM, et al. Pituitary hormones regulaie c-myc and DNA synthesis in lymphoid tissue. J Immunol. 1991;146:2201-2206.
10. Roth JA, Kaeberle ML, Grier RL, et al. Improvement in clinical condition and thymus morphologic features associated with growth hormone treatment of immunodeficient dwarf dogs. Am J Vet Res. 1984;:45:1151-1155.
11. Grunstein RR, Ho KY, Berthen-jones M, et al. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hyper-secretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med. 1994;15:496-502.
12. Glass AR. Endocrine aspects of obesity. Med Clin North Am. 1989;73:139-160.
13. Cappa M, Loche S, Borrelli P, et al. Growth hormone response to growth hormone-releasing hormone 1-40 in Turner's syndrome. Horm Res. 1987; 27:1-6.
14. Christiansen JS, Orskov H, Binder C, Kastrup KW. Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to GH deficient children. Acta Endocrinol. 1983;102:6-10.
15. Albertsson-Winkland K, Westphal O, Westgren U. Daily subcutaneous administration of human growth hormone in GH-defident children. Acta Endocrinol. 1986;75:89-97.
16. Bletben SL, Allen DB, Graves D, et al. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab. 1996;81:1704-1710.